On the road to Boston for Clinical Trials in Oncology East Coast 2024! 🚙 If you'll be there too, stop by booth 8️⃣ and see Scout's strategies to optimize oncology trial operations, helping to keep studies on track and within the allocated budget. #OncologyTrials #ClinicalResearch
Scout’s Post
More Relevant Posts
-
Australia, with its robust healthcare infrastructure and access to diverse patient populations, can play a pivotal role in accelerating clinical trials. Our upcoming webinar will delve into a real world case study, showcasing how Australia’s data can be leveraged effectively. We’ll explore a clinical development plan that tackles the unique challenges encountered by sponsors during oncology drug development. Join us on 21 May to gain valuable insights and learn strategies for overcoming obstacles in early phase oncology studies. https://bit.ly/3V7dzjY #ClinicalDevelopment #EarlyPhaseOncology #Webinar
-
-
🌟 Big news for the clinical research community! Clario is thrilled to present our expanded Oncology Trial Solutions Portfolio, featuring cutting-edge endpoint collection technologies. Discover what sets us apart in our latest press release in the link below! #ClinicalAdvancements #OncologyTrials
-
Navigating the complexity of clinical trials to bring therapies to market faster, and on budget
🌟 Big news for the clinical research community! Clario is thrilled to present our expanded Oncology Trial Solutions Portfolio, featuring cutting-edge endpoint collection technologies. Discover what sets us apart in our latest press release in the link below! #ClinicalAdvancements #OncologyTrials
Clario Reveals Updated Oncology Trial Solutions Portfolio: The Industry's Widest Range of Endpoint Collection Technologies | Clario
clario.shp.so
-
🌟 Big news for the clinical research community! Clario is thrilled to present our expanded Oncology Trial Solutions Portfolio, featuring cutting-edge endpoint collection technologies. Discover what sets us apart in our latest press release in the link below! #ClinicalAdvancements #OncologyTrials
Clario Reveals Updated Oncology Trial Solutions Portfolio: The Industry's Widest Range of Endpoint Collection Technologies | Clario
clario.shp.so
-
Psychologist | Talent Acquisition Partner @ Clario | HR, Global Talent Acquisition, Business Management, DEI |
🌟 Big news for the clinical research community! Clario is thrilled to present our expanded Oncology Trial Solutions Portfolio, featuring cutting-edge endpoint collection technologies. Discover what sets us apart in our latest press release in the link below! #ClinicalAdvancements #OncologyTrials
Clario Reveals Updated Oncology Trial Solutions Portfolio: The Industry's Widest Range of Endpoint Collection Technologies | Clario
clario.shp.so
-
Join Caidya this Friday at 11am EST/4pm GMT for an insightful webinar on the Strategic Implications of Oncology Clinical Trial Design in Early-Phase Studies. Hosted by Caidya and Xtalks, this webinar will provide valuable insights into the latest trends and strategies in clinical trial design. Don't miss this discussion on novel trial designs, the importance of dose-finding studies in early-phase trials to later registrational trials, and more. Register now: https://lnkd.in/dXWiibJD #webinar #clinicaltrialdesign #oncologyresearch
-
-
Preparing for #ESMO: Thrilled to be attending the prestigious ESMO (European Society for Medical Oncology) conference in Madrid this year. ESMO is a leading event in the field of medical oncology that brings together industry experts, clinicians, researchers, and pharma professionals, offering an unparalleled opportunity to exchange knowledge and keep up with the latest advancements in the field of cancer treatment. This conference holds immense value for me and our organization. It allows us to stay at the forefront of the rapidly evolving oncology landscape and foster collaborations with key stakeholders in the industry. Attending ESMO is a testament to Simbec Orion's commitment to advancing cancer research and our dedication to improving patient outcomes. Our team will be actively participating in discussions about our latest research findings, and engaging in networking opportunities with like-minded professionals from across the globe. This conference provides an excellent platform to showcase our expertise and innovation in clinical research, particularly in the areas of early-phase oncology trials, biomarkers, and novel therapeutic interventions. By staying connected to the latest breakthroughs and emerging trends in the fast-paced world of oncology, we can better serve our clients and ultimately contribute to advancements in cancer treatment. I am looking forward to building connections, exchanging ideas, and exploring potential collaborations that will drive Simbec Orion's mission of accelerating drug development and ultimately benefiting patients worldwide. If you are attending ESMO and would like to connect, I would be delighted to meet and discuss how we can work together to make a tangible impact in the fight against cancer. Stay tuned for exciting updates during the conference! 🎉 #ESMO2023 #Oncology #ClinicalResearch #MedicalOncology #CancerResearch #SimbecOrion #BusinessDevelopment #Networking #Collaboration
With almost 3 decades of experience in the delivery of oncology clinical trials, including rare oncology, we understand how to manage these complex studies. Our teams design and conduct a comprehensive portfolio of trials, from First in Human, Phase I/II adaptive trials, through to Phase III studies. Continually striving for transparent and honest partnerships with our clients, we are supported by a world-leading, independent oncology advisory board who are ready to guide your program toward your target exit strategy, be it asset sale or registration. Romillie Cruz, MD and Alain Thibault MD are excited to be attending #ESMO23 Contact us to set up a meeting in Madrid https://bit.ly/3tcSBot
Leverage 3 decades of oncology trial expertise: meet us at ESMO 2023
https://vimeo.com/
-
Flexibility, reactivity, and global coordination are crucial for ensuring the success of a clinical trial. Discover how Median Technologies executed nearly 200 site startups in 2 months for a critical Phase III oncology study. Learn how study sponsor achieved rapid turnaround for site initiation with minimal burden on investigators. Read the full case study below 👇 or on our website: https://lnkd.in/e4NAr7N6 #oncologytrials #medicalimaging #studyrescue
-
Navigating the ever-evolving landscape of clinical trials can be a complex task, especially during the critical Study Start-Up phase. Delays at this stage can significantly impact timelines and budgets. TrialNAV is here to offer valuable services aimed at assisting trials facing challenges during Study Start-Up. We’re dedicated to helping streamline the process and ensuring the success of your trials. #clinicaltrials #studystartup #TrialNAV
Are you struggling with reaching site activation milestones for your early phase oncology trials? You are not alone. Stay tuned for the next few weeks as we highlight common pitfalls and consequences in perhaps the most critical stage of a trial’s life cycle: study start up. Find out why TrialNAV is rescuing study start-up services from other providers and how we can help you. #SSU #earlyphase #oncologytrials
